Clinical Trials Browser

Mesothelioma × Everolimus × Clear all

NCT02071862 2022-07-20

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

Phase 1 Completed

BreastGenitourinaryOther solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Mesothelioma, Triple Negative Breast Neoplasms

NCT01024946 2015-05-12

Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity

Phase 2 Completed

11 enrolled 6 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma